FDA approves ribociclib plus letrozole to treat a subset of advanced breast cancer patients.
The 13th edition EMD Serono Specialty Digest outlines top specialty drug management issues health plans face.
A new study led by The University of California researchers and published in JAMA reveals surprising findings.
Based on new data from 2 large clinical trials, FDA is warning that these blockbuster type 2 diabetes medications can cause an increased risk of leg and foot amputations.
FDA expanded the use of ivacaftor (Kalydeco, Vertex Pharmaceuticals) to treat cystic fibrosis.
Scott Gottlieb, MD, was sworn in as the new FDA commissioner and ushers in a new era.
Soon after approving the same drug for metastatic Merkel cell carcinoma, FDA approved immuno-oncology avelumab (Bavencio) for locally advanced or metastatic urothelial carcinoma.
Walmart, CVS Health, and a number of other healthcare organizations are supporting a new multi-million dollar consumer campaign to combat high prescription drug prices.
Late last week, FDA approved a new drug to treat acute myeloid leukemia (AML), the first treatment for Batten disease, and expanded the use of a current drug to treat liver cancer.